Advertisement

Topics

ASCO 2017 – Head and Neck Cancer – Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab

22:17 EDT 31 Jul 2017 | GRACE

Drs. Jared Weiss, Josh Bauml, and Siddharth Sheth gathered post ASCO 2017 to discuss new information regarding head and neck cancers. In this roundtable video, the doctors discuss the alternative to every three week Cisplatin - weekly Cisplatin and Cetuximab.

Original Article: ASCO 2017 – Head and Neck Cancer – Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab

NEXT ARTICLE

More From BioPortfolio on "ASCO 2017 – Head and Neck Cancer – Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab"

Quick Search
Advertisement